Sundrug Co.,Ltd. Statistics
Total Valuation
Sundrug Co.,Ltd. has a market cap or net worth of JPY 491.73 billion. The enterprise value is 462.75 billion.
Market Cap | 491.73B |
Enterprise Value | 462.75B |
Important Dates
The next estimated earnings date is Friday, February 14, 2025.
Earnings Date | Feb 14, 2025 |
Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Sundrug Co.,Ltd. has 116.97 million shares outstanding. The number of shares has increased by 0.02% in one year.
Current Share Class | n/a |
Shares Outstanding | 116.97M |
Shares Change (YoY) | +0.02% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 4.59% |
Owned by Institutions (%) | 27.70% |
Float | 67.02M |
Valuation Ratios
The trailing PE ratio is 16.76 and the forward PE ratio is 15.75. Sundrug Co.,Ltd.'s PEG ratio is 3.78.
PE Ratio | 16.76 |
Forward PE | 15.75 |
PS Ratio | 0.63 |
PB Ratio | 1.89 |
P/TBV Ratio | 1.95 |
P/FCF Ratio | 164.24 |
P/OCF Ratio | n/a |
PEG Ratio | 3.78 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.11, with an EV/FCF ratio of 154.56.
EV / Earnings | 15.77 |
EV / Sales | 0.60 |
EV / EBITDA | 8.11 |
EV / EBIT | 11.36 |
EV / FCF | 154.56 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.13.
Current Ratio | 1.74 |
Quick Ratio | 0.76 |
Debt / Equity | 0.13 |
Debt / EBITDA | 0.59 |
Debt / FCF | 11.49 |
Interest Coverage | 577.76 |
Financial Efficiency
Return on equity (ROE) is 11.61% and return on invested capital (ROIC) is 9.63%.
Return on Equity (ROE) | 11.61% |
Return on Assets (ROA) | 6.58% |
Return on Invested Capital (ROIC) | 9.63% |
Return on Capital Employed (ROCE) | 13.71% |
Revenue Per Employee | 116.43M |
Profits Per Employee | 4.40M |
Employee Count | 6,662 |
Asset Turnover | 1.96 |
Inventory Turnover | 6.45 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.10% in the last 52 weeks. The beta is 0.22, so Sundrug Co.,Ltd.'s price volatility has been lower than the market average.
Beta (5Y) | 0.22 |
52-Week Price Change | -6.10% |
50-Day Moving Average | 3,922.14 |
200-Day Moving Average | 4,037.47 |
Relative Strength Index (RSI) | 65.87 |
Average Volume (20 Days) | 331,160 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sundrug Co.,Ltd. had revenue of JPY 775.66 billion and earned 29.34 billion in profits. Earnings per share was 250.88.
Revenue | 775.66B |
Gross Profit | 196.04B |
Operating Income | 41.60B |
Pretax Income | 41.14B |
Net Income | 29.34B |
EBITDA | 57.92B |
EBIT | 41.60B |
Earnings Per Share (EPS) | 250.88 |
Balance Sheet
The company has 63.39 billion in cash and 34.42 billion in debt, giving a net cash position of 28.98 billion or 247.74 per share.
Cash & Cash Equivalents | 63.39B |
Total Debt | 34.42B |
Net Cash | 28.98B |
Net Cash Per Share | 247.74 |
Equity (Book Value) | 260.76B |
Book Value Per Share | 2,229.34 |
Working Capital | 86.10B |
Cash Flow
In the last 12 months, operating cash flow was 36.96 billion and capital expenditures -33.97 billion, giving a free cash flow of 2.99 billion.
Operating Cash Flow | 36.96B |
Capital Expenditures | -33.97B |
Free Cash Flow | 2.99B |
FCF Per Share | 25.60 |
Margins
Gross margin is 25.27%, with operating and profit margins of 5.36% and 3.78%.
Gross Margin | 25.27% |
Operating Margin | 5.36% |
Pretax Margin | 5.30% |
Profit Margin | 3.78% |
EBITDA Margin | 7.47% |
EBIT Margin | 5.36% |
FCF Margin | 0.39% |
Dividends & Yields
This stock pays an annual dividend of 130.00, which amounts to a dividend yield of 3.08%.
Dividend Per Share | 130.00 |
Dividend Yield | 3.08% |
Dividend Growth (YoY) | 14.04% |
Years of Dividend Growth | 6 |
Payout Ratio | 45.43% |
Buyback Yield | -0.02% |
Shareholder Yield | 3.06% |
Earnings Yield | 5.97% |
FCF Yield | 0.61% |
Stock Splits
The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.
Last Split Date | Mar 29, 2017 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Sundrug Co.,Ltd. has an Altman Z-Score of 5.16.
Altman Z-Score | 5.16 |
Piotroski F-Score | n/a |